CapEx at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s capex?
- Aquestive Therapeutics, Inc. (AQST) reported capex of $52K in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s capex changed year-over-year?
- Aquestive Therapeutics, Inc.'s capex decreased by 61.5% year-over-year, from $135K to $52K.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s capex?
- Over 4 years (2021 to 2025), Aquestive Therapeutics, Inc.'s capex has grown at a -11.4% compound annual growth rate (CAGR), from $913K to $562K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.